Anti-factor Xa determination in blood: a new method for controlling heparin therapy.
Harenberg
J
J
First Department of Medicine, Faculty of Clinical Medicine, University of Heidelberg, Mannheim, Germany.
Haaf
B
B
Schäfer
M
M
Dempfle
C E
CE
Stehle
G
G
Heene
D L
DL
D000328:Adult; D000553:Ambulatory Care; D000906:Antibodies / Q000097:blood*; D015951:Factor Xa / Q000276:immunology*; D005260:Female; D006493:Heparin / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006495:Heparin, Low-Molecular-Weight / Q000493:pharmacokinetics / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011446:Prospective Studies; D012016:Reference Values; D006435:Renal Dialysis
D000906:Antibodies; D006495:Heparin, Low-Molecular-Weight; D006493:Heparin; D015951:Factor Xa